The cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in Turkey

Simple item page
dc.contributor.authorMalhan, Simten
dc.contributor.authorPay, Salih
dc.contributor.authorAtaman, Şebnem
dc.contributor.authorDinç, Ayhan
dc.contributor.authorErken, Eren
dc.contributor.authorErtenli, İhsan
dc.contributor.authorErtuǧrul, Esin
dc.contributor.authorGöǧüş, Feride Nur
dc.contributor.authorHamuryudan, Vedat
dc.contributor.authorİnanç, Murat
dc.contributor.authorKaraaslan, Yaşar
dc.contributor.authorKaradağ, Ömer
dc.contributor.authorKarakoç, Yüksel
dc.contributor.authorKeskin, Göksal
dc.contributor.authorKısacık, Bünyamin
dc.contributor.authorKiraz, Sedat
dc.contributor.authorOksel, Fahrettin
dc.contributor.authorÖksüz, Ergün
dc.contributor.authorPırıldar, Timur
dc.contributor.authorSarı, İsmail
dc.contributor.authorSoy, Mehmet
dc.contributor.authorŞentürk, Taşkın
dc.contributor.authorTaylan, Ali
dc.contributor.buuauthorDalkılıç, Ediz
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi.tr_TR
dc.contributor.scopusid6506739457tr_TR
dc.date.accessioned2022-04-01T11:05:51Z
dc.date.available2022-04-01T11:05:51Z
dc.date.issued2012
dc.description.abstractObjectives: To determine the direct and indirect costs due to rheumatoid arthritis (RA) and ankylosing spondylitis (AS) patients in Turkey. Methods: An expert panel was convened to estimate the direct and indirect costs of care of patients with RA and AS in Turkey. The panel was composed of 22 experts chosen from all national tertiary care rheumatology units (n=53). To calculate direct costs, the medical management of RA and AS patients was estimated using "cost-of-illness" methodology. To measure indirect costs, the number of days of sick leave, the extent of disability, and the levels of early retirement and early death were also evaluated. Lost productivity costs were calculated using the "human capital approach", based on the minimum wage. Results: The total annual direct costs were 2,917.03 Euros per RA patient and 3,565.9 Euros for each AS patient. The direct costs were thus substantial, but the indirect costs were much higher because of extensive morbidity and mortality rates. The total annual indirect costs were 7,058.99 Euros per RA patient and 6,989.81 for each AS patient. Thus, the total cost for each RA patient was 9,976.01 Euros and that for an AS patient 10,555.72 Euros, in Turkey. Conclusion: From the societal perspective, both RA and AS have become burden in Turkey. The cost of lost productivity is higher than the medical cost. Another important conclusion is that indirect costs constitute 70% and 66% of total costs in patients with RA and AS, respectively.en_US
dc.description.sponsorshipAbbott Companyen_US
dc.identifier.citationMalhan, S. vd. (2012). "The cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in Turkey". Clinical and Experimental Rheumatology, 30(2), 202-207.en_US
dc.identifier.endpage207tr_TR
dc.identifier.issn0392-856X
dc.identifier.issn1593-098X
dc.identifier.issue2tr_TR
dc.identifier.pubmed22546069tr_TR
dc.identifier.scopus2-s2.0-84863751510tr_TR
dc.identifier.startpage202tr_TR
dc.identifier.urihttp://hdl.handle.net/11452/25518
dc.identifier.volume30tr_TR
dc.identifier.wos000303905800010tr_TR
dc.indexed.pubmedPubMeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherClinical & Exper Rheumatologyen_US
dc.relation.collaborationYurt içitr_TR
dc.relation.collaborationSanayitr_TR
dc.relation.journalClinical and Experimental Rheumatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectRheumatologyen_US
dc.subjectRheumatoid arthritisen_US
dc.subjectAnkylosing spondylitisen_US
dc.subjectCosten_US
dc.subjectTurkeyen_US
dc.subjectProductivity costsen_US
dc.subjectWork disabilityen_US
dc.subjectEconomic burdenen_US
dc.subjectEmploymenten_US
dc.subjectPrevalenceen_US
dc.subjectIllnessen_US
dc.subjectİzmiren_US
dc.subject.emtreeAnkylosing spondylitisen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeCost benefit analysisen_US
dc.subject.emtreeCost of illnessen_US
dc.subject.emtreeDeathen_US
dc.subject.emtreeDisability severityen_US
dc.subject.emtreeDisease courseen_US
dc.subject.emtreeDrug costen_US
dc.subject.emtreeHealth care costen_US
dc.subject.emtreeHospital costen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeMedical leaveen_US
dc.subject.emtreeMorbidityen_US
dc.subject.emtreeMortalityen_US
dc.subject.emtreePatient careen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreeProductivityen_US
dc.subject.emtreeRetirementen_US
dc.subject.emtreeRheumatoid arthritisen_US
dc.subject.emtreeTertiary health careen_US
dc.subject.emtreeTurkey (republic)en_US
dc.subject.meshAbsenteeismen_US
dc.subject.meshArthritis, rheumatoiden_US
dc.subject.meshCost of illnessen_US
dc.subject.meshDisability evaluationen_US
dc.subject.meshHospital costsen_US
dc.subject.meshHospital unitsen_US
dc.subject.meshHumansen_US
dc.subject.meshModels, economicen_US
dc.subject.meshPrognosisen_US
dc.subject.meshRetirementen_US
dc.subject.meshRheumatologyen_US
dc.subject.meshSick leaveen_US
dc.subject.meshSpondylitis, ankylosingen_US
dc.subject.meshTurkeyen_US
dc.subject.scopusAnkylosing Spondylitis; Sacroiliac Joint; Spondylarthropathiesen_US
dc.subject.wosRheumatologyen_US
dc.titleThe cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in Turkeyen_US
dc.typeArticle
dc.wos.quartileQ2en_US

Files

License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Web of Science
Scopus